EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Six-Point Supraperiosteum Injection with Calcium Hydroxyapatite for Jawline Refining and Facial Anti-aging in Asian Patients

Bing-Qi Wu, Yun-Jhen Lin, Chang-Cheng Chang iD, Man-Lok Lio, Wei-Chun Chang, Hsiu-Mei Chiang, Yung-Hsueh Huang, Ying-Chuan Hsu

Aesthetic Plastic Surgery · 2025

DOI: 10.1007/s00266-025-05045-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aesthetic Plastic Surgery, 2025. Verfasst von Bing-Qi Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Education, China Medical University Hospital, Taichung, 404, Taiwan. Hauptthemen laut MEDLINE: Cosmetic Techniques, Dermal Fillers, Durapatite, Rejuvenation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xcodes Co., LTD..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Supraperiosteal injection by calcium hydroxyapatite (CaHA) fillers is an efficient treatment for facial rejuvenation to achieve bony recontouring, facial augmentation and lifting. However, a safe and efficient injection technique for Asians was not described, and an assessment scale to quantify “facial anti-aging” does not exist.

Methods

We enrolled 16 Asian women ( n = 32) to receive a single session of six-point calcium hydroxyapatite (CaHA, Radiesse® Plus) filler injections between July 1, 2021, and July 1, 2022. The six injection sites included the eyebrow arch, lateral eyebrow, lateral zygoma, piriform fossa, lateral chin, and anteromedial cheek. Efficacy was assessed at weeks 0 (immediately post-treatment), 4, 12, and 24 using a specialized angular and length measurement system, with outcomes further evaluated using an 11-level anti-aging scale.

Results

Among the four angular and six linear parameters assessed, statistically significant variations were observed across five time points. Regarding post hoc analyses, the Eyebrow-Tail angle showed a statistically significant change at week 24, increasing by 2.84° ( p < 0.001) and corresponding to an anti-aging scale value of 6. This parameter indicated eyebrow lifting. The Tragus-Oral (−10.4 mm, p = 0.004) and Lower Facial Contouring (−9.8 mm, p = 0.044) showed statistically significant reductions and received aging scale ratings of 10 and 9, respectively, at week 24. These two parameters indicated achieving jawline refining. Overall, the final anti-aging scale improved from an average of 50–59, with minimal or ignorable ecchymosis and swelling at week 24.

Conclusions

The 6-point calcium hydroxyapatite filler injection achieved facial rejuvenation. After a single session, the injection recontoured the jawline and lifted the eyebrow tail. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine Ratings, please refer to Table of Contents or online Instructions to Authors www.springer.com/00266

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cosmetic TechniquesDermal FillersDurapatiteRejuvenationSkin AgingAdultFemaleHumansMiddle AgedAsian PeopleEstheticsFaceFollow-Up StudiesTreatment Outcome

Stichwörter der Autor:innen

Anti-agingCalcium hydroxylapatiteFacial rejuvenationSupraperiosteal injection

Substanzen

Dermal FillersDurapatite

Autor:innen und Institutionen

  • Department of Education, China Medical University Hospital, Taichung, 404, Taiwan.
  • School of Medicine, College of Medicine, China Medical University, No. 2, Yude Rd., North Dist., Taichung, 40402, Taiwan.
  • Department of Medical Education, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.
  • School of Medicine, College of Medicine, China Medical University, No. 2, Yude Rd., North Dist., Taichung, 40402, Taiwan. changcc1975@gmail.com.
  • Department of Cosmeceutics, China Medical University, Taichung, 40402, Taiwan. changcc1975@gmail.com.
  • Division of Plastic and Reconstructive Surgery, Department of Surgery, China Medical University Hospital, Taichung, 404, Taiwan. changcc1975@gmail.com.

ORCID-Profile: Chang-Cheng Chang

Förderung

  • Xcodes Co., LTD.

Zitieren

APA

Wu, B. Q., Lin, Y. J., Chang, C. C., Lio, M. L., Chang, W. C., Chiang, H. M., Huang, Y. H., & Hsu, Y. C. (2025). A Novel Six-Point Supraperiosteum Injection with Calcium Hydroxyapatite for Jawline Refining and Facial Anti-aging in Asian Patients. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-025-05045-x

Vancouver

Wu BQ, Lin YJ, Chang CC, Lio ML, Chang WC, Chiang HM, et al. A Novel Six-Point Supraperiosteum Injection with Calcium Hydroxyapatite for Jawline Refining and Facial Anti-aging in Asian Patients. Aesthetic Plastic Surgery. 2025. doi:10.1007/s00266-025-05045-x

BibTeX
@article{Wu2025,
  author = {Wu, Bing-Qi and Lin, Yun-Jhen and Chang, Chang-Cheng and Lio, Man-Lok and Chang, Wei-Chun and Chiang, Hsiu-Mei and Huang, Yung-Hsueh and Hsu, Ying-Chuan},
  title = {A Novel Six-Point Supraperiosteum Injection with Calcium Hydroxyapatite for Jawline Refining and Facial Anti-aging in Asian Patients},
  journal = {Aesthetic Plastic Surgery},
  year = {2025},
  doi = {10.1007/s00266-025-05045-x}
}
Kostenlos starten →